23. Nishikura, K., and J.M. Murray. 1987. Antisense RNA of proto-oncogene c-fos blocks renewed 
growth of quiescent 3T3 cells. Mol. Cell. Biol. 7:639-649. 
24. Wong PMC, Karlsson S, Holt JT, Redner RL, Turner P, and Nienhuis AW. Transfer of Genes into 
Hematopoietic Cells Using Retroviral Vectors. In: Proceedings of the UCLA symposia on Biology of 
Leukemias and Lymphomas. Golde D.(ed.), Alan R. Liss, Inc. 61:553-566, 1988. 
25. Holt, JT. Antisense rescue defines Specialized and Generalized functions for c-fos protein during 
cell growth. Mol. Cell. Biol. 13:3821-3820, 1993 
26. Holt JT. Growth Inhibition by Antisense Nucleic Acids. In: Discoveries in Antisense Nucleic 
Acids. Brakel C. (ed.), Gulf Press. 2:81-94, 1989. 
27. Kerr, L.D., J.T. Holt, and L. M. Matrisian. 1988. Growth factors regulate transin gene expression 
by c-fos dependent and c-fos independent pathways. Science 242: 1424-1427. 
28. Kim S-J., F Denhez, K-Y Kim, JT Holt, MB Spom, and AB Roberts. Activation of the second 
promoter of the TGF-betal gene by TGF-betal and phorbol ester occurs through the same target 
sequences. J.Biol.Chem. 264: 19373-19378,1989. 
29. Kovary,K., and R. Bravo. 1991. The Jun and Fos protein families are both required for cell cycle 
progression in fibroblasts. Mol. Cell. Biol. 11:4466-4472. 
30. Robinson-Benion, C., Salhany, K.E., Hann, S.R. and Holt, J.T.: Antisense inhibition of c-myc 
expression reveals common and distinct mechanisms of growth inhibition by TGF6 and TGFa. 
J.Cell.Biochem.,45: 188, 1991. 
3 1 . Momand J, GP Zambetti, DC Olsen, D George, and AJ Levine. The mdm-2 oncogene product 
forms a complex with the p53 protein and inhibits p53-mediated transformation. Cell 69: 1237-1245, 
1992. 
32. Johnson, R.S., B.M. Spiegelman, and V. Papaioannou. 1992. Pleiotropic effects of a null mutation 
in the c-fos proto-oncogene. Cell 71: 577-586. 
33. Field,S., R.S. Johnson, R. Mortenson, V.E. Papaioannou, B.M. Spiegelman, and M.E. 
Greenberg. 1992. Fos is not required for the growth or differentiation of ES cells. Proc.Natl. Acad.Sci. 
USA 89:9306-9310. 
34. Munger, K., J.A. Pietenpol, M.A. Pittelkow, J.T. Holt, and H.L. Moses. TGFbeta regulation of c- 
myc expression, pRB phosphorylation, and cell cycle progression in keratinocytes. Cell Growth and 
Differentiation 3:291-298, 1992. 
35. Pietenpol JA, JT Holt, RW Stein, and HL Moses. TGF-betal suppression of c-myc gene 
transcription inhibits keratinocyte proliferation. Proc.Natl.Acad.Sci.USA. 87:3758-3762, 1990. 
36. Pietenpol JA, RW Stein, E Moran, P Yaciuk, et.al. TGF-Betal inhibition of c-myc transcription 
and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell 
61:777-785,1990. 
37. Moscionio, AD, J Rozga, DF Neuzil, RW Overell, JT Holt, and AA Demetriou. In vivo regional 
delivery of retrovirally mediated foreign genes to rat liver cells: need for partial hepatectomy for successful 
foreign gene expression. Surgery 113:304-311, 1993. 
38. Ram Z, S Walbridge, EM Oshiro, JJ Viola, Y Chiang, SN Mueller, RM Blaese, and EH Oldfield. 
Intrathecal gene therapy for malignant leptomeningeal neoplasia. Cancer Res. 54:2141-2145,1994. 
39. Miller AD, DG Miller, JV Garcia, and CM Lynch. Use of retroviral vectors for gene transfer and 
expression. Methods in Enzym. 217: 581-599. 
Recombinant DNA Research, Volume 20 
[177] 
